Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.33696/2689-2812.2.013
A Novel Class of RIP1 or RIP3 Dual Inhibitors
Ting Zhou1, Bo Liu1,2,*
- 1Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA
- 2Department of Cellular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA
Corresponding Author
Bo Liu, liub@surgery.wisc.edu
Received Date: November 22, 2019
Accepted Date: January 02, 2020
Citation:
Zhou T, Liu B. A Novel Class of RIP1/RIP3 Dual Inhibitors. J Cell Immunol. 2020; 2(1): 15-17.
Copyright: © 2020 Zhou T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.